
Article Menu
Need Help?
No Article Versions Notes Found
Cite
Tiberi, D.; Vavassis, P.; Nguyen, D.; Guilbert, M.C.; Simon-Cloutier, A.; Dubé, P.; Gervais, M.K.; Sideris, L.; Leblanc, G.; Hijal, T.; Dufresne, M.P.; Yassa, M. Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer. Curr. Oncol. 2020, 27, 155-158. https://doi.org/10.3747/co.27.6059
Tiberi D, Vavassis P, Nguyen D, Guilbert MC, Simon-Cloutier A, Dubé P, Gervais MK, Sideris L, Leblanc G, Hijal T, Dufresne MP, Yassa M. Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer. Current Oncology. 2020; 27(3):155-158. https://doi.org/10.3747/co.27.6059
Chicago/Turabian StyleTiberi, D., P. Vavassis, D. Nguyen, M.C. Guilbert, A. Simon-Cloutier, P. Dubé, M.K. Gervais, L. Sideris, G. Leblanc, T. Hijal, M.P. Dufresne, and M. Yassa. 2020. "Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer" Current Oncology 27, no. 3: 155-158. https://doi.org/10.3747/co.27.6059